Skip to main content

URMC Logo

URMC / Research / Research@URMC
New Technologies May Speed Flu Vaccine Testing

New Technologies May Speed Flu Vaccine Testing

The AIR™ Platform, a silicon chip and imaging system marketed by Adarza Biosystems, can detect immune responses to flu virus and vaccines alike.  With a small blood sample, doctors can confirm a suspected flu infection, see if a vaccine induces a desired immune response, or predict which strains of flu will affect people in the coming flu season.

9/12/2016
From Flu to Smallpox, URMC Clinical Trials Lead the Way to Vaccines

From Flu to Smallpox, URMC Clinical Trials Lead the Way to Vaccines

The Vaccine Research Unit at the University of Rochester Medical Center began conducting vaccine trials in the 1970s. Their work has led to the approval of new flu vaccines and the first and only vaccine to prevent cancer and continues today with studies of bird flu and norovirus. 

6/9/2016
World AIDS Day Scientific Symposium Highlights Vaccine Research, Honors Community Leader

World AIDS Day Scientific Symposium Highlights Vaccine Research, Honors Community Leader

In celebration of World AIDS Day the University of Rochester Center for AIDS Research hosted a scientific symposium featuring a discussion of HIV vaccine research, research posters by students and post-doctoral fellows training at UR, and an award for a longtime HIV/AIDS physician and community advocate.

12/2/2015
International Experts, Student Research Featured at World AIDS Day Symposium

International Experts, Student Research Featured at World AIDS Day Symposium

In honor of World AIDS Day, celebrated on December 1, 2013, the UR Center for AIDS Research (CFAR) hosted a scientific symposium featuring talks from prestigious experts in the AIDS community and research posters from undergraduate and graduate students and post doctoral associates training at UR. 

12/9/2013
Bird Flu is Back in China: URMC Testing Vaccine Candidate

Bird Flu is Back in China: URMC Testing Vaccine Candidate

Two new cases of H7N9 bird flu were reported in China in October. With funding from the National Institutes of Health, the University’s Vaccine Research Unit is testing a new vaccine candidate in case H7N9 makes its way to the U.S. 

10/31/2013
12